Galectin Therapeutics Stock Price on December 3, 2024
| GALT Stock | USD 1.15 0.28 32.18% |
Below is the normalized historical share price chart for Galectin Therapeutics extending back to September 04, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Galectin Therapeutics stands at 1.15, as last reported on the 30th of December, with the highest price reaching 1.47 and the lowest price hitting 0.90 during the day.
If you're considering investing in Galectin Stock, it is important to understand the factors that can impact its price. Galectin Therapeutics holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11% return per unit of risk over the last 3 months. Galectin Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Galectin Therapeutics' Risk Adjusted Performance of (0.07), market risk adjusted performance of (24.37), and Standard Deviation of 8.26 to validate the risk estimate we provide.
At this time, Galectin Therapeutics' Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 308.2 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 14.9 M in 2024. . Price Earnings Ratio is likely to drop to -2.55 in 2024. Price Book Value Ratio is likely to gain to -1.57 in 2024. Galectin Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of September 2002 | 200 Day MA 2.622 | 50 Day MA 2.3768 | Beta 0.629 |
Galectin |
Sharpe Ratio = -0.1102
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GALT |
Estimated Market Risk
| 8.44 actual daily | 75 75% of assets are less volatile |
Expected Return
| -0.93 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Galectin Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Galectin Therapeutics by adding Galectin Therapeutics to a well-diversified portfolio.
Price Book 207.6975 | Book Value (1.01) | Enterprise Value 151.9 M | Enterprise Value Ebitda (4.04) | Shares Float 43.1 M |
Related Headline
Madrigal Pharmaceuticals Headline on 3rd of December 2024
Disposition of 520 shares by Craves Fred B of Madrigal Pharm... by MacroaxisInsider
Filed transaction by Madrigal Pharmaceuticals Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Galectin Therapeutics Valuation on December 3, 2024
It is possible to determine the worth of Galectin Therapeutics on a given historical date. On December 3, 2024 Galectin was worth 2.8 at the beginning of the trading date compared to the closed value of 2.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Galectin Therapeutics stock. Still, in general, we apply an absolute valuation method to find Galectin Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Galectin Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Galectin Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.95 | 2.96 | 2.74 | 2.80 | 422,072 | |
12/03/2024 | 2.80 | 2.81 | 2.58 | 2.60 | 537,498 |
| 2.54 | 2.59 | 2.30 | 2.36 | 575,934 |
| Backtest Galectin Therapeutics | | | Galectin Therapeutics History | | | Galectin Therapeutics Valuation | Previous | Next |
Galectin Therapeutics Trading Date Momentum on December 3, 2024
| On December 04 2024 Galectin Therapeutics was traded for 2.36 at the closing time. The top price for the day was 2.59 and the lowest listed price was 2.30 . The trading volume for the day was 575.9 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 9.23% . The overall trading delta against the current closing price is 24.23% . |
Galectin Therapeutics Fundamentals Correlations and Trends
By evaluating Galectin Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Galectin Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Galectin financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Galectin Therapeutics Stock history
Galectin Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Galectin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Galectin Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Galectin Therapeutics stock prices may prove useful in developing a viable investing in Galectin Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 60.2 M | 63.2 M | |
| Net Loss | -35 M | -36.7 M |
Galectin Therapeutics Quarterly Net Working Capital |
|
Galectin Therapeutics Stock Technical Analysis
Galectin Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Galectin Therapeutics Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Galectin Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Galectin Therapeutics December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Galectin Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Galectin Therapeutics shares will generate the highest return on investment. By undertsting and applying Galectin Therapeutics stock market strength indicators, traders can identify Galectin Therapeutics entry and exit signals to maximize returns
Galectin Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Galectin Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Galectin Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Galectin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.85) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | (24.38) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Galectin Stock Analysis
When running Galectin Therapeutics' price analysis, check to measure Galectin Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galectin Therapeutics is operating at the current time. Most of Galectin Therapeutics' value examination focuses on studying past and present price action to predict the probability of Galectin Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galectin Therapeutics' price. Additionally, you may evaluate how the addition of Galectin Therapeutics to your portfolios can decrease your overall portfolio volatility.